Evidence map›Paper›PMID 30859152›Full record

ArticleHepatology communications2019

Evidence for a Novel Regulatory Interaction Involving Cyclin D1, Lipid Droplets, Lipolysis, and Cell Cycle Progression in Hepatocytes.

Heng Wu, Jonathan M Ploeger, Sushama Kamarajugadda, Douglas G Mashek, Mara T Mashek, Juan C Manivel, Laurie L Shekels, Jessica L Lapiro, Jeffrey H Albrecht

Open access · goldAbstract read
In one paragraph

Article in Hepatology communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.4field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Small-Molecule Inhibitors Targeting Lipolysis in Human Adipocytes.Journal of the American Chemical Society · 2022
    Article
  8. Review
  9. Article
  10. Review
  11. Adipose triglyceride lipase activity regulates cancer cell proliferation via AMP-kinase and mTOR signaling.Biochimica et biophysica acta. Molecular and cell biology of lipids · 2020
    Article
  12. A negative reciprocal regulatory axis between cyclin D1 and HNF4α modulates cell cycle progression and metabolism in the liver.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Heng WuGastroenterology Division Minneapolis VA Health Care System Minneapolis MN.
Jonathan M PloegerDepartment of Biochemistry, Molecular Biology, and Biophysics University of Minnesota Minneapolis MN.
Sushama KamarajugaddaGastroenterology Division Minneapolis VA Health Care System Minneapolis MN.
Douglas G MashekDepartment of Biochemistry, Molecular Biology, and Biophysics University of Minnesota Minneapolis MN.
Mara T MashekDepartment of Biochemistry, Molecular Biology, and Biophysics University of Minnesota Minneapolis MN.
Juan C ManivelDepartment of Pathology Minneapolis VA Health Care System Minneapolis MN.
Laurie L ShekelsGastroenterology Division Minneapolis VA Health Care System Minneapolis MN.
Jessica L LapiroGastroenterology Division Minneapolis VA Health Care System Minneapolis MN.
Jeffrey H AlbrechtGastroenterology Division Minneapolis VA Health Care System Minneapolis MN.ORCID https://orcid.org/0000-0002-9472-6085
University of Minnesota · USMinneapolis VA Health Care System · US

Funding

The Cyclin D1/CDK4 Complex in Hepatocyte ProliferationR01DK054921 · NIDDK · UNIVERSITY OF MINNESOTA · PI ALBRECHT, JEFFREY H · 1998 to 2017
$4.5M
Regulation and consequences of hepatic lipid droplet catabolismR01DK114401 · NIDDK · UNIVERSITY OF MINNESOTA · PI MASHEK, DOUGLAS G · 2017 to 2020
$1.7M
Role of ATGL and lipid metabolism in healthspanR01AG055452 · NIA · UNIVERSITY OF MINNESOTA · PI MASHEK, DOUGLAS G · 2017 to 2021
$1.6M
Synergistic effects of diet, lipolytic signaling and SIRT1 on energy metabolismR01DK108790 · NIDDK · UNIVERSITY OF MINNESOTA · PI MASHEK, DOUGLAS G · 2016 to 2018
$1.1M
NIA NIH HHS R01 AG055452NIDDK NIH HHS R01 DK054921NIDDK NIH HHS R01 DK108790NIDDK NIH HHS R01 DK114401
6 · The paper itself

Abstract

During normal proliferation, hepatocytes accumulate triglycerides (TGs) in lipid droplets (LDs), but the underlying mechanisms and functional significance of this steatosis are unknown. In the current study, we examined the coordinated regulation of cell cycle progression and LD accumulation. As previously shown, hepatocytes develop increased LD content after mitogen stimulation. Cyclin D1, in addition to regulating proliferation, was both necessary and sufficient to promote LD accumulation in response to mitogens. Interestingly, cyclin D1 promotes LD accumulation by inhibiting the breakdown of TGs by lipolysis through a mechanism involving decreased lipophagy, the autophagic degradation of LDs. To examine whether inhibition of lipolysis is important for cell cycle progression, we overexpressed adipose TG lipase (ATGL), a key enzyme involved in TG breakdown. As expected, ATGL reduced LD content but also markedly inhibited hepatocyte proliferation, suggesting that lipolysis regulates a previously uncharacterized cell cycle checkpoint. Consistent with this, in mitogen-stimulated cells with small interfering RNA-mediated depletion of cyclin D1 (which inhibits proliferation and stimulates lipolysis), concurrent ATGL knockdown restored progression into S phase. Following partial hepatectomy, a model of robust hepatocyte proliferation

Identifiers

PMID30859152
PMCPMC6396375
OpenAlexW2913394134

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.